Alibaba Health Information Technology logo

Alibaba Health Information Technology

Asia, Beijing, China, Beijing

Description

AliHealth is a company that helps people get health insurance and get treatment as well.

Investor Profile

Alibaba Health Information Technology has backed more than 3 startups, with 1 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C, Series B rounds (top funding stages).
  • Majority of deals are located in China.
  • Strong thematic focus on Biotechnology, Health Diagnostics, Oncology.

Stage Focus

  • Series C (67%)
  • Series B (33%)

Country Focus

  • China (100%)

Industry Focus

  • Biotechnology
  • Health Diagnostics
  • Oncology
  • Health Care
  • Life Science
  • Medical
  • Biopharma
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Alibaba Health Information Technology frequently co-invest with?

Sharewin Investment
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Baidu Ventures
Asia, Beijing, China, Beijing
Co-Investments: 2
CCB Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
Fortune Capital
North America, Florida, United States, Coral Gables
Co-Investments: 1
Jinmao Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
Junci Investment
Asia, Shanghai, China, Shanghai
Co-Investments: 1
CCB International
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 2
GGV Capital
North America, California, United States, Menlo Park
Co-Investments: 2
Harvest Capital
North America, New Hampshire, United States, Concord
Co-Investments: 1
Fortune Venture Capital
Asia, Guangdong, China, Shenzhen
Co-Investments: 1

What are some of recent deals done by Alibaba Health Information Technology?

XellSmart

Minhang, Shanghai, China

Xellsmart develops stem cell treatment solutions for a variety of degenerative diseases for which there are now no clinical treatments.

BiopharmaBiotechnologyPharmaceutical
Series BOct 21, 2024
Amount Raised: $14,046,917
Geneplus-Beijing Co. Ltd.

Huakang, Anhui, China

Provider of gene sequencing and detection solutions used in cancer research and treatment.

BiotechnologyHealth DiagnosticsOncology
Series CJul 22, 2021
Amount Raised: $115,907,089
Beijing Gene+ Technology

Changping, Beijing, China

Beijing Gene+, also known as Beijing Gene Plus, provides gene testing services for cancer prevention

Health CareLife ScienceMedical
Series CJul 22, 2021
Amount Raised: $115,907,089